DaVita (DVA)
(Delayed Data from NYSE)
$161.57 USD
-0.01 (-0.01%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $161.18 -0.39 (-0.24%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth B Momentum B VGM
Company Summary
Denver, CO-headquartered DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.
DaVita’s Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis ...
Company Summary
Denver, CO-headquartered DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.
DaVita’s Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers.
The company’s other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
DaVita’s U.S. dialysis revenues (91% of FY22 revenues) are derived primarily from its core business of providing dialysis services and related laboratory services and, to some extent, the administration of pharmaceuticals and management fees generated from providing management and administrative services to certain outpatient dialysis centers. The sources of U.S. dialysis revenues are principally from government-based programs, including Medicare and Medicare Advantage (MA) plans, Medicaid and managed Medicaid plans, other government-based programs, including DaVita’s agreement with the Veterans Administration, and commercial insurance plans.
2023 at a Glance
DaVita’s 2023 revenues totaled $12.14 billion, up 4.6%.
DaVita derives revenues from two sources — Dialysis patient service revenues (95.3% of total revenues, up 3.6% from 2022) and Other - Ancillary services (4.7%, up 30.4%).
General Information
DaVita Inc
2000 16TH STREET
DENVER, CO 80202
Phone: 720-631-2100
Fax: 302-636-5454
Email: ir@davita.com
Industry | Medical - Outpatient and Home Healthcare |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/5/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 2.76 |
Current Year EPS Consensus Estimate | 9.99 |
Estimated Long-Term EPS Growth Rate | 17.50 |
Exp Earnings Date | 11/5/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 161.58 |
52 Week High | 166.04 |
52 Week Low | 71.51 |
Beta | 0.87 |
20 Day Moving Average | 786,984.62 |
Target Price Consensus | 155.86 |
4 Week | 4.41 |
12 Week | 16.57 |
YTD | 54.24 |
4 Week | 2.56 |
12 Week | 11.61 |
YTD | 28.65 |
Shares Outstanding (millions) | 83.90 |
Market Capitalization (millions) | 13,556.56 |
Short Ratio | NA |
Last Split Date | 9/9/2013 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 16.18 |
Trailing 12 Months | 16.67 |
PEG Ratio | 0.93 |
vs. Previous Year | 24.52% |
vs. Previous Quarter | 8.82% |
vs. Previous Year | 6.21% |
vs. Previous Quarter | 3.78% |
Price/Book | 16.67 |
Price/Cash Flow | 9.61 |
Price / Sales | 1.08 |
6/30/24 | 77.00 |
3/31/24 | 68.52 |
12/31/23 | 64.42 |
6/30/24 | 5.19 |
3/31/24 | 4.98 |
12/31/23 | 4.63 |
6/30/24 | 1.16 |
3/31/24 | 1.43 |
12/31/23 | 1.19 |
6/30/24 | 1.12 |
3/31/24 | 1.37 |
12/31/23 | 1.13 |
6/30/24 | 7.08 |
3/31/24 | 6.89 |
12/31/23 | 6.43 |
6/30/24 | 6.86 |
3/31/24 | 6.61 |
12/31/23 | 5.70 |
6/30/24 | 11.26 |
3/31/24 | 10.81 |
12/31/23 | 9.70 |
6/30/24 | 9.69 |
3/31/24 | 12.91 |
12/31/23 | 13.63 |
6/30/24 | 64.17 |
3/31/24 | 65.57 |
12/31/23 | 70.84 |
6/30/24 | 9.94 |
3/31/24 | 7.95 |
12/31/23 | 6.65 |
6/30/24 | 92.18 |
3/31/24 | 90.27 |
12/31/23 | 88.70 |